N. Corsico

522 total citations
32 papers, 439 citations indexed

About

N. Corsico is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, N. Corsico has authored 32 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Biochemistry, 12 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in N. Corsico's work include Metabolism and Genetic Disorders (13 papers), Mitochondrial Function and Pathology (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). N. Corsico is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Mitochondrial Function and Pathology (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). N. Corsico collaborates with scholars based in Italy, Switzerland and Albania. N. Corsico's co-authors include E. Arrigoni Martelli, E. Arrigoni‐Martelli, Menotti Calvani, Eugenia Morabito, Domenico Barone, Loredana Vesci, Stefania Rossi, Roberto Biselli, Ashraf Virmani and Andrea Fattorossi and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

N. Corsico

30 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Corsico Italy 11 200 131 85 83 60 32 439
Kanoo Hosoki Japan 11 174 0.9× 91 0.7× 55 0.6× 49 0.6× 93 1.6× 64 481
Mary S. Sutphin United States 14 173 0.9× 95 0.7× 53 0.6× 44 0.5× 62 1.0× 17 639
Patricia M. Kralik United States 12 171 0.9× 60 0.5× 58 0.7× 50 0.6× 135 2.3× 18 606
Baiba Švalbe Latvia 19 326 1.6× 146 1.1× 100 1.2× 166 2.0× 33 0.6× 34 655
S. Franchi‐Micheli Italy 14 231 1.2× 139 1.1× 184 2.2× 22 0.3× 38 0.6× 39 557
Angelo Mancinelli Italy 17 288 1.4× 88 0.7× 239 2.8× 178 2.1× 15 0.3× 33 720
Katsuji Hoshi Japan 13 197 1.0× 70 0.5× 136 1.6× 25 0.3× 74 1.2× 50 485
A. Pinelli Italy 12 132 0.7× 66 0.5× 80 0.9× 12 0.1× 59 1.0× 66 434
Norman R. Eade Canada 10 142 0.7× 73 0.6× 68 0.8× 29 0.3× 28 0.5× 19 512
Hiroyuki Hasegawa Japan 16 256 1.3× 315 2.4× 92 1.1× 202 2.4× 44 0.7× 45 639

Countries citing papers authored by N. Corsico

Since Specialization
Citations

This map shows the geographic impact of N. Corsico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Corsico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Corsico more than expected).

Fields of papers citing papers by N. Corsico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Corsico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Corsico. The network helps show where N. Corsico may publish in the future.

Co-authorship network of co-authors of N. Corsico

This figure shows the co-authorship network connecting the top 25 collaborators of N. Corsico. A scholar is included among the top collaborators of N. Corsico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Corsico. N. Corsico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrari, Paolo, Lucia Torielli, Mara Ferrandi, et al.. (1998). PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain. Journal of Pharmacology and Experimental Therapeutics. 285(1). 83–94. 80 indexed citations
2.
Virmani, Ashraf, Roberto Biselli, Stefania Rossi, et al.. (1995). Protective actions of l-carnitine and acetyl-l-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors. Pharmacological Research. 32(6). 383–389. 86 indexed citations
3.
Mancinelli, R., et al.. (1995). Positive action of propionyl-l-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy. European Journal of Pharmacology. 287(3). 303–307. 6 indexed citations
4.
Vesci, Loredana, et al.. (1995). Characterization and Subcellular Localization of l‐[3H]Carnitine Binding Sites in Rat Brain. Journal of Neurochemistry. 64(6). 2783–2791. 7 indexed citations
5.
Arduini, Arduino, Secondo Dottori, N. Corsico, et al.. (1995). Effect of propionyl-L-carnitine treatment on membrane phospholipid fatty acid turnover in diabetic rat erythrocytes. Molecular and Cellular Biochemistry. 152(1). 31–37. 7 indexed citations
6.
Vesci, Loredana, et al.. (1995). Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats. Pharmacological Research. 32(6). 363–367. 14 indexed citations
7.
Corsico, N., et al.. (1995). Propionyl‐L‐Carnitine Improves Mechanical Performance of Papillary Muscle from Dilated Cardiomyopathic Hamsters. Annals of the New York Academy of Sciences. 752(1). 207–209. 3 indexed citations
8.
Pascale, Alessia, et al.. (1994). Protein kinase C activation and anti-amnesic effect of acetyl-L-carnitine: in vitro and in vivo studies. European Journal of Pharmacology. 265(1-2). 1–7. 33 indexed citations
9.
Morabito, Eugenia, N. Corsico, & E. Arrigoni Martelli. (1994). Endothelins urinary excretion is increased in spontaneously diabetic rats: BB/BB. Life Sciences. 56(1). PL13–PL18. 11 indexed citations
10.
Morabito, Eugenia, et al.. (1994). Elevated urinary excretion of endothelins in streptozotocin diabetic rats. Life Sciences. 54(11). PL197–PL200. 20 indexed citations
11.
Vesci, Loredana, et al.. (1994). Decreased density of endothelin binding sites in adrenal glands but not in aorta, of long term infarcted rats. Life Sciences. 55(22). PL421–PL424. 1 indexed citations
12.
Morabito, Eugenia, N. Corsico, A Marzo, & E. Arrigoni Martelli. (1994). Serum and urine levels of levocarnitine family components in genetically diabetic rats.. PubMed. 44(8). 965–8. 4 indexed citations
13.
Corsico, N., A. Nardone, Luigi Giusto Spagnoli, et al.. (1993). Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: A functional, histologic, and NMR spectroscopic study. Cardiovascular Drugs and Therapy. 7(2). 241–251. 25 indexed citations
14.
Bonanno, Elena, et al.. (1993). Cytosine arabinoside modulates endothelial cell proliferation in ?in vitro? angiogenesis. Cytotechnology. 11(S1). S155–S155. 1 indexed citations
15.
Malone, John I., et al.. (1992). Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.. PubMed. 12(5-6). 237–41. 12 indexed citations
16.
Lazzarino, Giuseppe, et al.. (1992). [L-propionylcarnitine taurine amide induces the metabolic recovery of the isolated postischemic rat heart].. PubMed. 37(10). 715–7. 2 indexed citations
17.
Tarzia, Giorgio, et al.. (1988). 6-(Alkylamino)-3-aryl-1,2,4-triazolo[3,4-a]phthalazines. A new class of benzodiazepine receptor ligands. Journal of Medicinal Chemistry. 31(6). 1115–1123. 51 indexed citations
18.
TOJA, E., et al.. (1987). Anti-hypertensives: 1-alkyl-2-arylpiperazinoethyl-1H-naphth[1,2-d]imidazoles. European Journal of Medicinal Chemistry. 22(3). 221–228. 4 indexed citations
19.
Bianchi, Giuseppe, et al.. (1985). Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.. PubMed. 35(5). 818–26. 3 indexed citations
20.
Corsico, N., et al.. (1975). [Pharmaco-toxicologic evaluation of a new anti-inflammatory non-steroid agent: indoxamic acid].. PubMed. 114(6). 319–33.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026